Rudy Li
Stock Analyst at Wolfe Research
(4.86)
# 376
Out of 5,090 analysts
83
Total ratings
46.3%
Success rate
58.7%
Average return
Main Sectors:
Stocks Rated by Rudy Li
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DRUG Bright Minds Biosciences | Initiated Coverage: Buy | $80 → $150 | $54.98 | +172.83% | 3 | Oct 15, 2026 | |
| OVID Ovid Therapeutics | Initiated Coverage: Buy | $5 | $2.54 | +96.85% | 1 | Oct 15, 2026 | |
| RAPP Rapport Therapeutics | Initiated Coverage: Buy | $50 | $25.05 | +99.60% | 1 | Oct 15, 2026 | |
| HRMY Harmony Biosciences Holdings | Initiated Coverage: Buy | $60 | $38.76 | +54.80% | 1 | Aug 26, 2026 | |
| IMUX Immunic | Reiterated: Buy | $30 → $25 | $7.51 | +232.89% | 3 | Aug 11, 2026 | |
| STOK Stoke Therapeutics | Reiterated: Buy | $40 | $26.29 | +52.15% | 20 | Aug 3, 2026 | |
| QURE uniQure | Upgraded: Buy | $65 | $24.83 | +161.78% | 2 | Jul 29, 2026 | |
| CMPS COMPASS Pathways | Reiterated: Buy | $18 | $11.57 | +55.57% | 1 | Jul 7, 2026 | |
| LBRX LB Pharmaceuticals | Initiated Coverage: Buy | $45 | $39.70 | +13.35% | 1 | Jul 7, 2026 | |
| SPTX Seaport Therapeutics | Initiated Coverage: Hold | n/a | $19.60 | - | 1 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 | $20.59 | +60.27% | 2 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $160 | $146.10 | +9.51% | 2 | Apr 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $500 | $285.93 | +74.87% | 7 | Apr 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $45 | $45.34 | -0.75% | 2 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $230 | $144.43 | +59.25% | 1 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 → $25 | $36.33 | -31.19% | 11 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $18.94 | - | 1 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $55 → $60 | $37.41 | +60.38% | 5 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $18 | $8.47 | +112.51% | 15 | Dec 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $22.60 | n/a | 2 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $40 | $0.35 | n/a | 1 | Sep 29, 2025 |
Bright Minds Biosciences
Oct 15, 2026
Initiated Coverage: Buy
Price Target: $80 → $150
Current: $54.98
Upside: +172.83%
Ovid Therapeutics
Oct 15, 2026
Initiated Coverage: Buy
Price Target: $5
Current: $2.54
Upside: +96.85%
Rapport Therapeutics
Oct 15, 2026
Initiated Coverage: Buy
Price Target: $50
Current: $25.05
Upside: +99.60%
Harmony Biosciences Holdings
Aug 26, 2026
Initiated Coverage: Buy
Price Target: $60
Current: $38.76
Upside: +54.80%
Immunic
Aug 11, 2026
Reiterated: Buy
Price Target: $30 → $25
Current: $7.51
Upside: +232.89%
Stoke Therapeutics
Aug 3, 2026
Reiterated: Buy
Price Target: $40
Current: $26.29
Upside: +52.15%
uniQure
Jul 29, 2026
Upgraded: Buy
Price Target: $65
Current: $24.83
Upside: +161.78%
COMPASS Pathways
Jul 7, 2026
Reiterated: Buy
Price Target: $18
Current: $11.57
Upside: +55.57%
LB Pharmaceuticals
Jul 7, 2026
Initiated Coverage: Buy
Price Target: $45
Current: $39.70
Upside: +13.35%
Seaport Therapeutics
Jul 7, 2026
Initiated Coverage: Hold
Price Target: n/a
Current: $19.60
Upside: -
May 6, 2026
Reiterated: Buy
Price Target: $33
Current: $20.59
Upside: +60.27%
Apr 6, 2026
Reiterated: Buy
Price Target: $160
Current: $146.10
Upside: +9.51%
Apr 6, 2026
Reiterated: Buy
Price Target: $500
Current: $285.93
Upside: +74.87%
Feb 23, 2026
Initiated Coverage: Buy
Price Target: $45
Current: $45.34
Upside: -0.75%
Feb 23, 2026
Initiated Coverage: Buy
Price Target: $230
Current: $144.43
Upside: +59.25%
Feb 23, 2026
Initiated Coverage: Buy
Price Target: $20 → $25
Current: $36.33
Upside: -31.19%
Feb 23, 2026
Initiated Coverage: Hold
Price Target: n/a
Current: $18.94
Upside: -
Feb 23, 2026
Initiated Coverage: Buy
Price Target: $55 → $60
Current: $37.41
Upside: +60.38%
Dec 31, 2025
Initiated Coverage: Buy
Price Target: $18
Current: $8.47
Upside: +112.51%
Oct 20, 2025
Reiterated: Buy
Price Target: $15
Current: $22.60
Upside: n/a
Sep 29, 2025
Initiated Coverage: Buy
Price Target: $40
Current: $0.35
Upside: n/a